Vitoc Vlad's Form 4/A amendment
AmendedMAIA Biotechnology, Inc. (MAIA) · filed Dec 4, 2025
- Accession no.
- 0001878313-25-000059
- Filed
- Dec 4, 2025
- Trade date
- Nov 26-28, 2025
- Filing delay
- 8 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 1, 2025
This filing lists 2 non-derivative transactions. Open-market purchases total $80.1K. It was filed 8 days after the trade.
This amendment replaces 0001878313-25-000056 (filed Dec 1, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vitoc VladCIK 0001913257 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F3
The original Form 4 filed on December 1, 2025 had the incorrect total share balance owned by Vlad Vitoc. This Amended Form 4 is now reflecting the correct share balance owned.
- F4
The original Form 4 filed on December 1, 2025 had the incorrect total share balance owned by Mr. Vitoc's spouse. This Amended Form 4 is now reflecting the correct share balance owned.
- F5
These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.